Stock Events

Stock Events

Apellis Pharmaceuticals (APLS) Q1 2025 Earnings

28FebConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.54

-0.46

-0.37

-0.29

Details

Expected EPS

-0.369463

Actual EPS

-0.29

Surprise EPS

0.08

Surprise Percent

+21.51%

Description

Apellis Pharmaceuticals (APLS) has reported earnings of -0.29 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.